Primary-angle closure glaucoma patients may experience a small increase in IOP after visual field testing, according to a study.
Author: Healio ophthalmology
LASIK effective for compound myopic astigmatism with high cylinder
LASIK with an optimized aspheric profile, cyclotorsion control and fast repetition rate corrected compound myopic astigmatism with high cylinder, according to a study.
Ivantis raises $27 million in financing to fund trials on microstent
Ivantis raised $27 million in a Series B round of financing for additional trials of its Hydrus microstent, according to a company news release.The device, which is about the size of an eyelash, according to the release, is designed to help re-establis…
Axial length a factor in phaco of microphthalmos, nanophthalmos eyes
Despite a series of challenges and risks, phacoemulsification with IOL implantation proved safe in eyes with microphthalmos and nanophthalmos, according to a study.The retrospective analysis included 103 eyes with axial length less than 21 mm that unde…
Perfluoropropane injection offers alternative treatment for vitreomacular traction
Intravitreal expansile perfluoropropane injection may be a minimally invasive alternative to pars plana vitrectomy in treatment of vitreomacular traction, according to a study.The retrospective, interventional case series included 15 eyes of 14 patient…
FDA clears Corvis ST tonometer
The Corvis ST, a non-contact tonometer and optical pachymeter from Oculus, received 510(k) clearance from the U.S. Food and Drug Administration, according to a company news release.
DALK with dry manual dissection yields positive visual, refractive outcomes
Deep anterior lamellar keratoplasty using a dry manual dissection technique compared favorably with other deep lamellar methods, according to a study.The retrospective study included 288 eyes of 268 patients who underwent DALK with a dry manual dissect…
Several factors may help predict outcome of lamellar macular hole surgery
After lamellar macular hole surgery, poor visual outcome may be predicted by poor initial visual acuity, a disrupted inner segment/outer segment junction or a thin fovea, according to a study.The retrospective review included 30 eyes of 30 consecutive …
Cataract surgery after vitrectomy may lead to macular edema
Patients with previous pars plana vitrectomy and internal limiting membrane peeling who later underwent successful cataract surgery frequently developed macular edema, according to a study.The study included 20 eyes of 20 patients with previous 23-gaug…
Cycloplegia with atropine may increase hyperopic shift, ocular higher-order aberrations
A significant hyperopic shift and an increase in ocular higher-order aberrations may occur in children after cycloplegia with topical atropine, according to a study.The prospective noncomparative study included 23 eyes of 23 subjects with hyperopia. Al…
Anti-VEGF treatment continues for years in most neovascular AMD patients
Ranibizumab treatment was discontinued in 21% of neovascular age-related macular degeneration patients because of complete inactivation of choroidal neovascularization, a long-term study found.Fifteen percent of patients failed to respond to treatment,…
Alcon launches once-daily NSAID for pain, inflammation after cataract surgery
Alcon has launched Ilevro suspension, a topical NSAID that treats pain and inflammation related to cataract surgery.Ilevro (nepafenac ophthalmic suspension 0.3%) is indicated for once-daily dosing, according to an Alcon news release.
Bausch + Lomb begins phase 3 studies of glaucoma drug candidate
Bausch + Lomb has begun a pair of phase 3 clinical studies on latanoprostene bunod to reduce IOP in patients with glaucoma or ocular hypertension, according to a company news release.The drug candidate, licensed from Nicox and previously known as BOL-3…
Sutureless intrascleral IOL implantation an option for post-traumatic aphakia
Sutureless intrascleral IOL implantation improved vision in patients with post-traumatic aphakia, according to a study.The interventional case series included 26 eyes of 23 patients with acute traumatic cataract who were divided into two groups. The fi…
Bausch + Lomb finalizes acquisition of Technolas Perfect Vision
With Bausch + Lomb’s completion of its acquisition of Technolas Perfect Vision, the new entity will be known as Bausch + Lomb Technolas, according to a company news release.“The Technolas Perfect Vision team, led by CEO Dr. Kristian Hohla, has built a ‘best in class’ femtosecond laser platform and other exciting ophthalmic products that round out Bausch + Lomb’s surgical product portfolio and position us to become a ‘one-stop shop’ for ophthalmic surgeons,” Brent Saunders, president and CEO of Bausch + Lomb, said in the release.
Plaque radiotherapy effective in managing iris melanoma
Plaque radiotherapy proved effective in managing patients with iris melanoma with a low risk for metastasis, according to a study.The retrospective case series included 144 patients with iris melanoma; 58 patients had secondary glaucoma at baseline exa…
BLOG: Sarcoidosis diagnosis and treatment
I have always been interested in sarcoidosis in the way it presents and its diagnostic dilemma, so I would like to pose three test questions and follow up with a discussion to build upon the questions.
Speaker: Corneal inlays moving closer to approval in US
WAIKOLOA, Hawaii — Two intracorneal inlays for the treatment of presbyopia may be nearing approval in the U.S., according to a speaker here.The ReVision Optics Raindrop inlay, composed of a disc of hydrogel that is implanted under a LASIK flap, is now completing its phase 3 U.S. Food and Drug Administration trial, OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, said at Hawaiian Eye 2013.
Bandage contact lenses under development as drug delivery vehicles
WAIKOLOA, Hawaii — Bandage contact lenses, which provide pain relief and comfort from exposed nerve endings that occur with corneal maladies such as corneal abrasions from corneal dystrophies, neurotrophic keratopathy, bullous keratopathy and postsurgical states, may also be developed into drug delivery vehicles, a speaker said here. “The motivating factor for this development is that the eye, the cornea in particular, has a very strong bioprotective mechanism. It allows low permeability of medicine to get into the eye. We know that the tear fluid that drains into the nasal cavity (Read more...)
Submacular hemorrhages may be managed with anti-VEGF
WAIKOLOA, Hawaii — Intravitreal injections may successfully help manage submacular hemorrhages, according to a speaker here.“We know that submacular hemorrhages have a significant variability in their clinical course,” Mark W. Johnson, MD, said at Retina 2013. “But it does seem that poor prognostic factors include thick blood under the fovea and the presence of AMD. And we know that when an eye has both of these factors, the final visual outcome if you don’t treat these is rarely better than 20/200.”